课题基金 / 基金详情

基于植物脂质组学的多基原中药海藻的鉴定研究

批准号:
81973433
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
刘红兵
依托单位:
学科分类:
中药鉴定
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
刘红兵

项目摘要

结项摘要

项目成果

刘红兵的其他基金

相似基金

相关文献

中文摘要
中药海藻为褐藻门马尾藻属羊栖菜和海蒿子的干燥藻体,是中国药典收载的两种海洋植物类中药材之一。市售海藻普遍存在混伪品,基本为马尾藻属植物数种混杂,传统鉴定很难区分物种;药典法测定岩藻糖计的多糖含量,与另一药典品种昆布方法相同。本项目旨在发现质量标志物,建立鉴别海藻真伪优劣的理化方法。项目组前期发现海藻脂质是其主要药效成分,脂肪酸、植物甾醇、甘油糖脂、萜类等不同结构类型的多个脂质分子,共同作用于核受体家族LXRs、PPARs、PXR等多个靶点发挥药效。本项目在前期基础上,运用植物脂质组学技术,采用色谱-串联质谱分析脂质多维轮廓谱,区分物种,发现化学分类标志物;以核受体为靶点,虚拟筛选并验证活性,建立马尾藻脂质数据库,从“化学网络-生物网络”发现药效指标成分。整合化学分类标志物和药效指标成分,提炼出质量标志物,建立海藻理化鉴定方法,保障临床用药安全有效,推动我国蓝色药库建设。
英文摘要
Traditional Chinese medicine SARGASSUM (PinYin: HAI ZAO), are originated from dried frond of Sargassum fusiforme and Sargassum pallidum according to the Chinese Pharmacopoeia. In the commercial materia medica SARGASSUM, it is common to see mixtures of several spices from Sargassum genus. Morphological and DNA barcoding could not solve all the problems in quality control. The aim of this project is to discover Q-markers and establish a chemical identifying method. Our previous studies found that lipids are the main effective components in SARGASSUM, which fatty acids, phytosterols, glycoglycerolipids, terpenoids are the main lipid types, and they act together on nuclear receptors LXRs, PPARs, PXR to exert their pharmacodynamic effects. Based on plant lipidomics technology, the present project analyzes the multi-dimensional lipid profiles Using GC-MS/MS or UPLC-MS/MS methods, for distinguishing species in Sargassum genus and obtaining Chemotaxonomy markers. Target to metabolic nuclear receptors, virtual drug screening of SARGASSUM lipids are carried out, and a seaweed-lipid database containing chemical and biology information was established. Through the established "chemical network-biological network", pharmacodynamics markers are obtained. Q-markers are then extracted from the integrated Chemotaxonomy markers and pharmacodynamic markers. Then, a simple, reliable and economical method for chemical identification of SARGASSUM is development. This study guarantees the safety and effectiveness of SARGASSUM clinical use, and promotes the construction of “China Blue Pharmacy Plan”.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.3390/ijms21165695
发表时间: 2020
期刊: International Journal of Molecular Sciences
影响因子:
作者: [Jiapeng Chen, Hongbing Liu]
通讯作者: Hongbing Liu
DOI: 10.3390/ijms24021290
发表时间: 2023-01-09
期刊: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子: 5.6
作者: [Zhan, Na, Wang, Boyang, Martens, Nikita, Liu, Yankai, Zhao, Shangge, Voortman, Gardi, Van Rooij, Jeroen, Leijten, Frank, Vanmierlo, Tim, Kuipers, Folkert, Jonker, Johan W., Bloks, Vincent W., Luetjohann, Dieter, Palumbo, Marcella, Zimetti, Francesca, Adorni, Maria Pia, Liu, Hongbing, Mulder, Monique T.]
通讯作者: Mulder, Monique T.
DOI: 10.1111/1750-3841.16596
发表时间: 2023-05-11
期刊: JOURNAL OF FOOD SCIENCE
影响因子: 3.9
作者: [Geng,Xicheng, Jia,Xuli, Liu,Tao]
通讯作者: Liu,Tao
DOI: 10.3390/md20030201
发表时间: 2022-03-09
期刊: Marine drugs
影响因子: 5.4
作者: [Ma WP, Yin SN, Chen JP, Geng XC, Liu MF, Li HH, Liu M, Liu HB]
通讯作者: Liu HB
10
    羊栖菜植物甾醇降血脂功能性成分及其作用机制研究
    • 批准号:
      31271845
    • 项目类别:
      面上项目
    • 资助金额:
      83.0万元
    • 批准年份:
      2012
    • 负责人:
      刘红兵
    • 依托单位:
    红树林根际土壤真菌Aspergillus glaucus血管生成抑制活性先导化合物的发现与优化
    • 批准号:
      30672527
    • 项目类别:
      面上项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2006
    • 负责人:
      刘红兵
    • 依托单位:
    源于海洋的放线菌A2-2002中抗肿瘤生物碱结构及构效关系的研究
    • 批准号:
      30300433
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      7.0万元
    • 批准年份:
      2003
    • 负责人:
      刘红兵
    • 依托单位:
    国内基金
    海外基金